Video Latest - ecancer

Review of olaparib for ovarian cancer

Dr Michel Vulfovich - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

Lung cancer immunotherapy

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

Best of ASCO 2016: Introduction and aims

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

'Other' targets in lung cancer

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

25 Jul 2016

Developments in gastrointestinal tumour treatment

Dr Ihor Pidhorecky - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists

Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

Editor's Choice for July 2016

Prof Gordon McVie - Editor in Chief, ecancer

25 Jul 2016

The steady progress of targeted therapies

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

20 Jul 2016

Towards deciphering the functional genetics and neo-antigenic landscape in melanoma

Prof Yardena Samuels - Weizmann Institute of Science, Rehovot, Israel

18 Jul 2016

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

17 Jul 2016

Polycomb repressors and epigenetic therapy

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

15 Jul 2016

DNA repair and mutations as targets for personalised therapy

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA

15 Jul 2016

Video